List view / Grid view
27 April 2015 | By
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) has issued a special excellence award to Médecins Sans Frontières...
27 April 2015 | By Victoria White
Professional medical writing improves the quality of clinical trial reporting, demonstrates a study presented at the 11th Annual Meeting of the ISMPP...
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
27 April 2015 | By Victoria White
CHMP has adopted a positive opinion, approving BMS’ ClickJect Pre-Filled Pen for use in adult patients with moderate to severe active rheumatoid arthritis...
27 April 2015 | By Victoria White
AbbVie announced new, preliminary safety and efficacy data from the first cohort of its ongoing, Phase 3b RUBY-I study at ILC 2015...
27 April 2015 | By Victoria White
The FDA has approved Cyramza in combination with FOLFIRI chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC)...
27 April 2015 | By Victoria White
Primary endpoints were successfully met in a Phase III clinical trial evaluating a 12-week daclatasvir-based regimen for the treatment of patients with HCV...
24 April 2015 | By Victoria White
ELPA has launched ‘C: My Journey’, an online resource where people diagnosed with HCV can go to find out more about the condition and how to get support...
24 April 2015 | By Victoria White
Phase III trial results of the RTS,S vaccine candidate show that it helped protect children from clinical malaria for at least 3 years after vaccination...
24 April 2015 | By Victoria White
The first patient has been enrolled in a Phase II study evaluating laquinimod, an investigational, oral, immune modulator, for the treatment of PPMS...
24 April 2015 | By Victoria White
Innate Pharma has signed a co-development and commercialisation agreement with AstraZeneca to accelerate and broaden the development of IPH2201...
24 April 2015 | By Victoria White
The CHMP has adopted a positive opinion recommending that Bristol-Myers Squibb’s Opdivo be granted approval for use in patients with advanced melanoma...
24 April 2015 | By Victoria White
The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spenders Regeneron and Vertex, says leading research and consulting firm GlobalData.
24 April 2015 | By Victoria White
TxCell has announced an amendment to the Ovasave collaboration option, development and license agreement (Ovasave Agreement) with Trizell...
24 April 2015 | By Victoria White
Young healthcare enthusiasts involved in the European Health Parliament will meet on Friday to push ahead with their ideas on Europe's future healthcare...
